Improvement of Targeted Chemotherapy of HER2-positive Ovarian Malignant Cell Line by Z<sub>HER2</sub>-Idarubicin Conjugate: An in vitro Study.
- Published in:
- Iranian Journal of Pathology, 2021, v. 16, n. 2, p. 109, doi. 10.30699/IJP.2020.120392.2310
- By:
- Publication type:
- Article